Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

In vivo Three-Dimensional Bioluminescence Tomography of Gene Expression: Pilot Results

324. Development of Bioluminescence Tomography for Three-Dimensional Real Time Imaging of Gene Expression

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

In Vitro and in Vivo Uncaging and Bioluminescence Imaging by Using Photocaged Upconversion Nanoparticles

Image-guided Simulation for Bioluminescence Tomographic Imaging.

Two-dimensional bioluminescence tomography: numerical simulations and phantom experiments.

Three-dimensional multi Bioluminescent sources reconstruction based on adaptive finite element method

Practical Reconstruction Method for Bioluminescence Tomography

Non-invasive Bioluminescence Imaging of Myoblast-Mediated Hypoxia-Inducible Factor-1 Alpha Gene Transfer

Brightening up Biology: Advances in Luciferase Systems for in Vivo Imaging

Quantitative Molecular Bioluminescence Tomography

In vivo ultrasound-induced luminescence molecular imaging

In vivo bioluminescence imaging of natural bacteria within deep tissues via ATP-binding cassette sugar transporter

Quantitative in vivo dual-color bioluminescence imaging in the mouse brain

Ultra-sensitive Single Pixel Bioluminescence Tomography for in Vivo Cell Tracking

Optical imaging of green fluorescent protein markers for tracking vascular gene expression: a feasibility study in human tissue-like phantoms

Identification of Factors Complicating Bioluminescence Imaging

Novel three-dimensional live skin-like in vitro composite for bioluminescence reporter gene assay

Three-dimensional Bioluminescence Tomography Based on Bayesian Approach

Three-Dimensional Bioluminescence Tomography Assisted by Diffuse Optical Tomography

Reconstruction Method for in Vivo Bioluminescence Tomography Based on the Split Bregman Iterative and Surrogate Functions